These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3490278)

  • 1. Chemical and biological characterization of low-molecular-weight human skeletal growth factor.
    Mohan S; Linkhart T; Jennings J; Baylink D
    Biochim Biophys Acta; 1986 Nov; 884(2):243-50. PubMed ID: 3490278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and purification of a low-molecular-weight skeletal growth factor from human bones.
    Mohan S; Jennings JC; Linkhart TA; Baylink DJ
    Biochim Biophys Acta; 1986 Nov; 884(2):234-42. PubMed ID: 3768416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal growth factor is produced by human osteoblast-like cells in culture.
    Wergedal JE; Mohan S; Taylor AK; Baylink DJ
    Biochim Biophys Acta; 1986 Nov; 889(2):163-70. PubMed ID: 3778945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor beta do not account for the cell growth activity present in bovine milk.
    Belford DA; Rogers ML; Francis GL; Payne C; Ballard FJ; Goddard C
    J Endocrinol; 1997 Jul; 154(1):45-55. PubMed ID: 9246937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II.
    Mohan S; Jennings JC; Linkhart TA; Baylink DJ
    Biochim Biophys Acta; 1988 Jul; 966(1):44-55. PubMed ID: 3390466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mitogenic activities extracted from bovine bone matrix.
    Linkhart TA; Jennings JC; Mohan S; Wakley GK; Baylink DJ
    Bone; 1986; 7(6):479-87. PubMed ID: 3467756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae.
    Centrella M; Canalis E
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7335-9. PubMed ID: 2997787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
    Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-beta in human dentin.
    Finkelman RD; Mohan S; Jennings JC; Taylor AK; Jepsen S; Baylink DJ
    J Bone Miner Res; 1990 Jul; 5(7):717-23. PubMed ID: 2396498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
    Anzano MA; Roberts AB; Smith JM; Sporn MB; De Larco JE
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6264-8. PubMed ID: 6604914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preliminary characterization of mitogens secreted by embryonic chick wing bud tissues in vitro.
    Bell KM
    J Embryol Exp Morphol; 1986 Apr; 93():257-65. PubMed ID: 3525735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
    Bowen-Pope DF; Dicorleto PE; Ross R
    J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of transforming growth factors on cell lines and their modification by other growth factors.
    Morita H; Noda K; Umeda M; Ono T
    Gan; 1984 May; 75(5):403-9. PubMed ID: 6378708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.
    Carpenter G; Stoscheck CM; Preston YA; DeLarco JE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5627-30. PubMed ID: 6310584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoma growth factor (SGF): specific binding to epidermal growth factor (EGF) membrane receptors.
    De Larco JE; Todaro GJ
    J Cell Physiol; 1980 Feb; 102(2):267-77. PubMed ID: 6246130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth factors on bone cell replication and differentiation.
    Canalis E
    Clin Orthop Relat Res; 1985 Mar; (193):246-63. PubMed ID: 3882294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of growth factors in human pituitary.
    Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
    Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.